- Home
- HIMS
as 10-08-2025 3:39pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 10.8B | IPO Year: | N/A |
| Target Price: | $37.20 | AVG Volume (30 days): | 28.9M |
| Analyst Decision: | Hold | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.79 | EPS Growth: | 866.21 |
| 52 Week Low/High: | $17.36 - $72.98 | Next Earning Date: | 11-03-2025 |
| Revenue: | $2,013,538,000 | Revenue Growth: | 88.69% |
| Revenue Growth (this year): | 61.66% | Revenue Growth (next year): | 19.48% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | HIMS | Chief Financial Officer | Oct 3 '25 | Sell | $57.72 | 11,595 | $669,232.09 | 70,232 | |
| Chi Michael | HIMS | Chief Commercial Officer | Oct 1 '25 | Sell | $56.00 | 250 | $14,000.00 | 291,439 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Sep 29 '25 | Sell | $58.79 | 2,637 | $155,029.23 | 163,767 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Sep 29 '25 | Sell | $60.20 | 85,000 | $5,116,923.50 | 70,232 | |
| Chi Michael | HIMS | Chief Commercial Officer | Sep 24 '25 | Sell | $56.52 | 2,100 | $118,692.00 | 291,439 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Sep 22 '25 | Sell | $57.74 | 23,584 | $1,361,766.10 | 70,232 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Sep 16 '25 | Sell | $53.58 | 175,661 | $9,384,625.36 | 113,940 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Sep 15 '25 | Sell | $55.52 | 145,000 | $8,026,075.61 | 70,232 | |
| Chi Michael | HIMS | Chief Commercial Officer | Sep 15 '25 | Sell | $56.00 | 4,150 | $232,400.00 | 291,439 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Aug 26 '25 | Sell | $43.69 | 11,581 | $505,968.10 | 70,232 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Motley Fool
5 days ago
Why Hims & Hers Stock Slipped Today
Zacks
5 days ago
Hims & Hers Expands Health Access Through Subscription Revenue Model
Simply Wall St.
6 days ago
Evaluating Hims & Hers Health (HIMS) Valuation After 39% Share Price Surge in the Past Month
Investor's Business Daily
6 days ago
Breakout Stocks Watch: What Looms For October?
StockStory
6 days ago
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
Zacks
7 days ago
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Motley Fool
8 days ago
The Secret to Finding the Next Amazon Is Hiding in Plain Sight
MT Newswires
8 days ago
Hims & Hers Health Insider Sold Shares Worth $5,116,924, According to a Recent SEC Filing
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.